查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1468401

按癌症類型（非小細胞肺癌 (NSCLC)、小細胞肺癌 (SCLC)）、標記類型（EGFR、EML4-ALK、KRAS、BRAF 等）、最終用戶（醫院、診斷）分類的肺部標記物市場報告實驗室等）和地區2024-2032

Lung Marker Market Report by Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Marker Type (EGFR, EML4-ALK, KRAS, BRAF, and Others), End User (Hospitals, Diagnostic Labs, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球IMARC Group標記市場規模達到4.382億美元。

一般來說，在肺部介入手術或肺部手術和診斷過程中會使用四種主要類型的肺部標記物，包括EGFR、EML4-ALK、KRAS和BRAF。此外，標記物也用於檢測、診斷、預測和監測腫瘤，並據此為患者制定治療方案。肺部標記僅與一些影像學檢查和活體組織切片一起用作識別癌症的附加工具。因此，肺部標記物廣泛用於醫院、門診外科診所、專科診所以及其他一些醫療機構的胸腔鏡手術。

肺部標記需求的不斷成長可歸因於全球空氣污染水平不斷增加導致胸腔積液、胸膜間皮瘤、胸膜斑塊等呼吸系統疾病的高盛行率。除此之外，大量被動吸煙以及肺癌家族史進一步增加了肺癌患者的數量，從而增加了對肺部標記的需求。此外，老年人口激增，加上忙碌的消費者生活方式導致高吸煙率，進一步增加了多種呼吸系統疾病的風險。除此之外，各國政府對肺癌等危及生命的疾病的早期診斷和預處理的醫療支出不斷增加，也推動了肺部標記物在全球範圍內的使用不斷增加。此外，對肺癌診斷和治療領域多項研發活動的投資不斷增加，進一步刺激了對肺部標記的需求。除此之外，醫院、手術中心、診所擴大使用肺部標記物及其在治療目的中的各種應用也刺激了產品需求。

本報告回答的關鍵問題：

  • 迄今為止，全球肺部標記市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球肺部標記市場有何影響？
  • 主要區域市場有哪些？
  • 根據癌症類型分類的市場是怎麼樣的？
  • 基於標記類型的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球肺部標記市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球肺標記物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依癌症類型

  • 非小細胞肺癌 (NSCLC)
    • 市場走向
    • 市場預測
  • 小細胞肺癌 (SCLC)
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按標記類型

  • 表皮生長因子受體
    • 市場走向
    • 市場預測
  • EML4-ALK
    • 市場走向
    • 市場預測
  • 克拉斯
    • 市場走向
    • 市場預測
  • 布拉夫
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診斷實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他
  • 中東和非洲
    • 土耳其
    • 伊朗
    • 其他

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格指標

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc.
    • Fujirebio Europe NV
    • Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • BioSpace, Inc.
Product Code: SR112024A2063

The global lung marker market size reached US$ 438.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,064.0 Million by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global lung marker market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cancer type, marker type and end user.

Breakup by Cancer Type:

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

EGFR

EML4-ALK

KRAS

BRAF

Others

Breakup by End User:

Hospitals

Diagnostic Labs

Others

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Peru

Others

Middle East and Africa

Turkey

Iran

Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Lung Marker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Non-Small Cell Lung Cancer (NSCLC)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Cell Lung Cancer (SCLC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Marker Type

  • 7.1 EGFR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 EML4-ALK
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 KRAS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 BRAF
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Iran
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Others
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Thermo Fisher Scientific Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agilent Technologies, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fujirebio Europe N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hologic, Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Siemens Healthineers
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 BioSpace, Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
  • Figure 2: Global: Lung Marker Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2023
  • Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2023
  • Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Turkey: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Iran: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Argentina: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Colombia: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Chile: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Peru: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Lung Marker Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Global: Lung Marker Industry: SWOT Analysis
  • Figure 91: Global: Lung Marker Industry: Value Chain Analysis
  • Figure 92: Global: Lung Marker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Lung Marker Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million US$), 2024-2032
  • Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million US$), 2024-2032
  • Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Lung Marker Market: Competitive Structure
  • Table 7: Global: Lung Marker Market: Key Players